4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine
C19H19ClN4S — CID 136639951
Data last refreshed: (MolForge compound catalog, from PubChem)
About 4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine
4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine (PubChem CID 136639951) has the molecular formula C19H19ClN4S and a molecular weight of 370.91 g/mol. Its IUPAC name is 4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine.
Molecular Properties
| Compound Name | 4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine |
|---|---|
| PubChem CID | 136639951 |
| Molecular Formula | C19H19ClN4S |
| Molecular Weight | 370.91 g/mol |
| Exact Mass | 370.10 |
| IUPAC Name | 4-(4-chloro-2-methylphenyl)-2-methyl-3-pyridin-2-yl-4,6,7,8-tetrahydropyrazolo[3,4-e][1,4]thiazepine |
| SMILES | Cc1cc(Cl)ccc1C1SCCNc2nn(C)c(-c3ccccn3)c21 |
| InChI | InChI=1S/C19H19ClN4S/c1-12-11-13(20)6-7-14(12)18-16-17(15-5-3-4-8-21-15)24(2)23-19(16)22-9-10-25-18/h3-8,11,18H,9-10H2,1-2H3,(H,22,23) |
| InChIKey | YBUPSEGAZUJWDB-UHFFFAOYSA-N |
| XLogP | 4.69 |
| TPSA | 42.74 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 2 |
| Heavy Atoms | 25 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 370.91 |
| LogP ≤ 5 | 4.69 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 136639951 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.